Cataldo Tony 4
4 · GT Biopharma, Inc. · Filed Jun 4, 2020
Insider Transaction Report
Form 4
Cataldo Tony
DirectorChairman and CEO
Transactions
- Sale
common stock
2020-06-02$0.00/sh−4,234,320$4,234→ 6,500,000 total
Footnotes (1)
- [F1]The disposal of the 4,234,320 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018.